Harbourvest Partners’s MacroGenics MGNX Stock Holding History

Harbourvest Partners’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-38,452	Closed	-$1.35M	–	21
2014 Q4	$1.35M	Buy	+38,452	New	+$959K	0.71%	17

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Harbourvest Partners's MGNX Position: Q1 2015 in Review

Harbourvest Partners sold out of MacroGenics (MGNX) in Q1 2015, closing a stake of 38,452 shares — an estimated $1.35M sold.

Harbourvest Partners first reported a position in MGNX in Q4 2014 and held it in 1 quarter. The position peaked at $1.35M in Q4 2014. 113 funds tracked by Wall St. Rank hold MGNX as of Q1 2015.

Harbourvest Partners reported no remaining MacroGenics position as of Q1 2015 after selling out during the quarter.
Harbourvest Partners sold 38,452 MacroGenics shares in Q1 2015, an estimated $1.35M.
Harbourvest Partners first reported a position in MacroGenics in Q4 2014 and held it in 1 quarter.
Harbourvest Partners's MacroGenics position peaked at $1.35M in Q4 2014.
113 funds tracked by Wall St. Rank held MacroGenics as of Q1 2015.

Based on Harbourvest Partners's 13F filing for Q1 2015, filed 8 May 2015.